These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9007141)

  • 41. [Chemotherapy for non-small cell lung cancer].
    Shinkai T; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():92-8. PubMed ID: 9216193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.
    Adjei AA; Argiris A; Murren JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):32-40; discussion 41-2. PubMed ID: 10585007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New drug and multimodality combinations in the treatment of advanced non--small cell lung cancer.
    Kawahara M; Kris MG; Green M; Kunitoh H
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):1-4. PubMed ID: 11441408
    [No Abstract]   [Full Text] [Related]  

  • 44. Improved survival with addition of bevacizumab to paclitaxel and carboplatin in elderly patients with non-small-cell lung cancer.
    Atkins CD
    J Clin Oncol; 2008 Apr; 26(12):2063-4; author reply 2064-5. PubMed ID: 18421066
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemotherapy for advanced non-small cell lung cancer: past, present, and future.
    Ramanathan RK; Belani CP
    Semin Oncol; 1997 Aug; 24(4):440-54. PubMed ID: 9280224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Combined modality treatment of lung cancer: present and future].
    Ohta M; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1986 Nov; 24(11):1186-91. PubMed ID: 3031350
    [No Abstract]   [Full Text] [Related]  

  • 47. Carboplatin and weekly paclitaxel for the treatment of advanced non-small cell lung cancer (NSCLC) during pregnancy.
    Azim HA; Scarfone G; Peccatori FA
    J Thorac Oncol; 2009 Apr; 4(4):559-60. PubMed ID: 19333076
    [No Abstract]   [Full Text] [Related]  

  • 48. Advanced non-small-cell lung cancer: to treat or not to treat?
    Hansen HH
    J Clin Oncol; 1987 Nov; 5(11):1711-2. PubMed ID: 2824704
    [No Abstract]   [Full Text] [Related]  

  • 49. [Proceedings of the 3rd National Conference of Medical Oncology. Irinotecan: present and future. Napoli, Italy, 5 November 2001].
    Tumori; 2001; 87(6):A29-37. PubMed ID: 11995704
    [No Abstract]   [Full Text] [Related]  

  • 50. Adjuvant therapy for non-small cell lung cancer.
    Evans WK
    Chest; 1989 Jul; 96(1 Suppl):87S-91S. PubMed ID: 2544378
    [No Abstract]   [Full Text] [Related]  

  • 51. [Data from the AACR 2018 meeting on the combination chimio-immunotherapy on advanced non-small cells lung cancer (NSCLC)].
    Simonneau Y; Ruppert AM; Chaabane N; Lavolé A; Wislez M
    Bull Cancer; 2018 Oct; 105(10):854-856. PubMed ID: 30262415
    [No Abstract]   [Full Text] [Related]  

  • 52. Report of the IASLC Le Havre Workshop.
    Arriagada R; Le Chevalier T
    Chest; 1989 Jul; 96(1 Suppl):82S-83S. PubMed ID: 2544375
    [No Abstract]   [Full Text] [Related]  

  • 53. Camptothecins resurface as promising drugs.
    Jenks S
    J Natl Cancer Inst; 1994 Aug; 86(15):1118-20. PubMed ID: 8028033
    [No Abstract]   [Full Text] [Related]  

  • 54. Selective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells.
    Ibrahim S; Gao D; Sinko PJ
    Nutr Cancer; 2014; 66(3):492-9. PubMed ID: 24063429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A combined epigenetic therapy equals the efficacy of conventional chemotherapy in refractory advanced non-small cell lung cancer.
    Rodríguez-Paredes M; Esteller M
    Cancer Discov; 2011 Dec; 1(7):557-9. PubMed ID: 22586680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. "When Roscius was an actor in Rome-" care for the elderly with N2-positive non-small-cell lung cancer.
    Osarogiagbon RU
    J Thorac Oncol; 2013 Jun; 8(6):670-2. PubMed ID: 23676556
    [No Abstract]   [Full Text] [Related]  

  • 57. Non-small cell lung cancer: report on the 5th central European lung cancer conference.
    Zatloukal P
    Biomed Pharmacother; 1999 Apr; 53(3):154-62. PubMed ID: 10349505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Future directions in clinical research for lung cancer.
    Bunn PA
    Chest; 1994 Dec; 106(6 Suppl):399S-407S. PubMed ID: 7988273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invited commentary.
    Kwong KF
    Ann Thorac Surg; 2013 Nov; 96(5):1789. PubMed ID: 24182464
    [No Abstract]   [Full Text] [Related]  

  • 60. TIME for a successful cancer vaccine in NSCLC?
    Butts CA; Sangha R
    Lancet Oncol; 2016 Feb; 17(2):131-132. PubMed ID: 26727164
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.